Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides

Name: Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Published: 2016
License: Public Domain

Pfizer · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

immunotherapy melanoma soft-tissue-sarcoma squamous-cell-carcinoma

solid tumors, mycosis fungoides, melanoma, merkel-cell carcinoma, squamous cell carcinoma, breast carcinoma, human papillomavirus-related malignant neoplasm, soft tissue sarcoma, cd47, sirpa, immunotherapy, checkpoint inhibitor

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 874538
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.